Su-Ming Chiang

Title: A Profile on Inventor Su-Ming Chiang: Pioneering Liposomal Drug Formulations

Introduction:

Su-Ming Chiang is a visionary inventor based in Canoga Park, California, with a remarkable portfolio of 10 patents under his belt. His groundbreaking work in pharmaceuticals has revolutionized the field of drug delivery, particularly in the realm of liposomal formulations.

Latest Patents:

1. Amphotericin B Liposome Preparation: Su-Ming Chiang's novel composition and method for solubilizing amphiphilic drugs in a small amount of organic solvent has paved the way for improved liposomes. By carefully controlling the pH during hydration, the resulting Amphotericin B liposomes exhibit significantly reduced toxicity.

2. Liposomal Camptothecin Formulations: Chiang's innovative liposomal encapsulated camptothecin formulations boast enhanced pharmacokinetics and efficacy as anti-tumor agents. These formulations, comprising phospholipids and camptothecin analogs, offer a superior therapeutic index compared to free drugs like topotecan.

Career Highlights:

Su-Ming Chiang has left an indelible mark on the pharmaceutical industry through his tenure at esteemed companies such as Nexstar Pharmaceuticals, Inc., and Gilead Sciences, Inc. His expertise and dedication have led to transformative advancements in drug delivery systems.

Collaborations:

Throughout his illustrious career, Su-Ming Chiang has collaborated with industry stalwarts including Richard T. Proffitt and Evan M. Hersch. Together, they have worked tirelessly to push the boundaries of innovative drug formulation technologies.

Conclusion:

Inventor Su-Ming Chiang's relentless pursuit of excellence and pioneering spirit have cemented his legacy as a trailblazer in the realm of liposomal drug formulations. His contributions continue to shape the future of pharmaceuticals, offering hope for enhanced treatment options and improved patient outcomes.